[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"total-hip-arthroplasty-tha\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:total-hip-arthroplasty-tha":28},{"pageToken":4,"total":5,"offset":6,"count":7,"results":8},null,27,0,25,[9,47,83,122,156,185,223,244,267,294,318,343,364,396,421,446,471,495,518,544,564,589,622,653,676],{"id":10,"slug":11,"hasResults":12,"nctId":13,"briefTitle":14,"officialTitle":15,"acronym":4,"eligibilityCriteria":16,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":29,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100644232","effects-of-foot-core-exercises-in-patients-with-total-hip-arthroplasty-100644232",false,"NCT07665801","Effects of Foot Core Exercises in Patients With Total Hip Arthroplasty","Investigation of the Effects of Foot Core Exercises on Lower Extremity Muscle Strength, Functional Parameters, and Morphological and Viscoelastic Properties of Foot and Ankle Periarticular Structures in Patients With Total Hip Arthroplasty","Inclusion Criteria:\n\n* Being between 50 and 80 years old,\n* Having at least 2 months elapsed since total hip arthroplasty surgery,\n* Being willing to participate in the study,\n* Being literate.\n\nExclusion Criteria:\n\n* Having undergone revision total hip arthroplasty surgery,\n* Having a cognitive level below 21 on the MoCA scale, or having any neurological or rheumatological disease,\n* Inability to ambulate,\n* Having any history of lower extremity trauma or other surgical procedures,\n* Having toe-related pathologies that may affect pressure distribution and the course of exercise, such as hallux valgus or Morton's neuroma.","ALL","50 Years","80 Years",{"count":21,"type":22},50,"ESTIMATED","INTERVENTIONAL",[25],"NA","The goal of this clinical trial is to investigate the effects of foot core exercises on lower extremity muscle strength, viscoelastic properties, functional parameters, foot and ankle posture, balance, and the morphological characteristics of periarticular structures of the foot and ankle in individuals with total hip arthroplasty. The main questions it aims to answer are:\n\n* Does foot core exercises affect morphological characteristics of the periarticular structures surrounding the foot and ankle?\n* Does foot core exercises affect viscoelastic properties of the periarticular structures surrounding the foot and ankle?\n* Does foot core exercises affect lower extremity muscle strength?\n* Does foot core exercises affect lower extremity functional parameters and balance in individuals with total hip arthroplasty?\n\nThe researchers will compare the group performing foot core exercises with the group performing routine hip exercises that do not include foot core exercises.\n\nParticipitants will:\n\n* Participants will receive an exercise log after a specialist physiotherapist demonstrates the exercises in practice at the third postoperative mounth.\n* Visit the clinic every two months from postoperative mounth 3 to month 7 for routine follow-ups and progression of exercises.\n* Except for the control sessions held every two mounths, patients will be followed up through weekly phone calls.\n* Participants will complete an exercise diary indicating that they performed the exercises prescribed for each week, and they will bring their diaries with them to the follow-up sessions.",[28],"Total Hip Arthroplasty (THA)",[30,31,32,33],"foot core exercises","ultrasound imaging","ultrasonography","Postoperative exercises","RECRUITING","2026-06-17",{"date":37,"type":38},"2026-06-24","ACTUAL",{"date":40,"type":38},"2026-03-23",{"date":42,"type":22},"2027-05-31",{"name":44,"class":45},"Hacettepe University","OTHER",1,{"id":48,"slug":49,"hasResults":12,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":12,"sex":17,"minAge":55,"maxAge":4,"enrollmentInfo":56,"targetDuration":4,"studyType":23,"phases":58,"briefSummary":60,"conditions":61,"keywords":65,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":75,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":46},"100594505","phase-2-brain-computer-interface-visualization-training-to-optimize-muscle-activation-following-orthopaedic-surgery-100594505","NCT07020312","Brain-Computer Interface Visualization Training to Optimize Muscle Activation Following Orthopaedic Surgery","Brain-Computer Interface Visualization Training to Optimize Muscle Activation Following Orthopaedic Surgery: A Blinded Randomized Controlled Trial","iBrainTechRCT","Participants\n\n* Inclusion Criteria:\n\n  * Patient age \\>18 years\n  * Ability to complete neurofeedback training and follow study follow-ups\n  * Indicated for one of the four investigated orthopedic procedures\n* Exclusion Criteria:\n\n  * Inability to participate in neurofeedback training\n  * Lack of decisional capability\n  * History of stroke, movement disorder (e.g. Parkinson's), peripheral neuropathy\n  * Cardiac pacemaker or other internal electronic device\n  * BMI \\>35\n  * Previous surgery or specific pathology on the affected joint (refer to procedure specific indications below)\n\nProcedure Specifics:\n\nAnterior cruciate ligament reconstruction (ACLR) Procedure-specific Inclusion Criteria\n\n* Patients undergoing primary ACLR with autograft or allograft tissue\n* Adjunct lateral Extra-articular tenodesis will be included\n* Additional meniscus debridement and repair will be included Procedure-specific exclusion criteria\n* Revision ACL surgery\n* Moderate to Severe arthritis - Kellgren-Lawerence (KL) Grade \\> 3\n* Patients with meniscus root repair\n* Non-weight-bearing status exceeding 1 week postoperatively\n\nTotal knee arthroplasty (TKA) Procedure specific inclusion criteria\n\n* Patients undergoing primary TKA\n* Preoperative total knee range of motion of at least 100 degrees (combined flexion and extension)\n* Prior extensor mechanism tendon repair, quadriceps or patella tendon. Procedure specific exclusion criteria\n* Revision surgery\n* Hinged implant\n* Any open procedure involving the knee joint\n* Symptomatic arthritis in the contralateral knee with planned or expected total knee arthroplasty within 6 months\n* Inflammatory Arthritis\n\nTotal hip arthroplasty (THA) Procedure Specific Inclusion Criteria\n\n* Patients undergoing primary THA Procedure Specific Exclusion Criteria\n* Revision Surgery\n* Any open procedure involving the hip joint\n* Bilateral THA procedures\n* Inflammatory Arthritis\n\nHip arthroscopy (HA) for femoroacetabular impingement syndrome (FAIS) Procedure Specific Inclusion Criteria\n\n· Patients undergoing HA for FAIS Procedure Specific Exclusion Criteria\n\n* Revision Surgery\n* Diagnosis of hip dysplasia","18 Years",{"count":57,"type":22},240,[59],"PHASE2","After orthopedic surgeries like knee or hip replacement, some patients struggle to fully activate their muscles due to a condition called Arthrogenic Muscle Inhibition (AMI). AMI can slow recovery and make physical therapy less effective. This clinical trial is testing whether a special type of brain training-called neurofeedback visualization training-can help improve muscle activation and speed up recovery.\n\nIn this study, patients will receive standard physical therapy after surgery. Half of them will also use a device that helps them \"visualize\" exercises while wearing a cap that reads brain signals (EEG). The cap tracks brain activity when patients imagine doing specific movements. A computer then shows a virtual avatar performing the movements, giving feedback in real time-like a video game controlled by the brain.\n\nThe study includes patients recovering from one of four surgeries:\n\n1. Anterior cruciate ligament reconstruction (ACLR)\n2. Total knee arthroplasty (TKA)\n3. Total hip arthroplasty (THA)\n4. Hip arthroscopy (HA) for femoroacetabular impingement (FAI)\n\nThe goal is to see if this training improves muscle strength, movement, and daily function more than standard therapy alone. The study will take place at Rush University Medical Center in Chicago and enroll 240 adults, with 60 patients per type of surgery. Each participant will be followed for up to 6 months after surgery and complete strength tests, movement assessments, and questionnaires about their recovery.\n\nThe hope is that combining brain training with physical therapy will lead to faster, more complete recoveries and improve how patients move after surgery.",[62,28,63,64],"Anterior Cruciate Ligament Reconstruction","Total Knee Arthroplasty","Hip Arthroscopy",[66,67,68,64,69,70,71,72,73,74],"ACLR","THA","TKA","Arthrogenic muscle inhibition","Electroencephalography","Gait","Motion Analysis","Biomechanics","Strength",{"date":76,"type":38},"2026-06-18",{"date":78,"type":38},"2025-08-14",{"date":80,"type":22},"2028-08-01",{"name":82,"class":45},"Rush University Medical Center",{"id":84,"slug":85,"hasResults":12,"nctId":86,"briefTitle":87,"officialTitle":88,"acronym":89,"eligibilityCriteria":90,"healthyVolunteers":12,"sex":17,"minAge":91,"maxAge":92,"enrollmentInfo":93,"targetDuration":4,"studyType":23,"phases":95,"briefSummary":96,"conditions":97,"keywords":99,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":114,"lastUpdatePostDateStruct":115,"startDateStruct":116,"completionDateStruct":118,"leadSponsor":120,"locationsCount":46},"100641994","wound-healing-dressing-type-and-dressing-change-frequency-in-tha-100641994","NCT07655388","Wound Healing, Dressing Type, and Dressing Change Frequency in THA","Impact of Dressing Type and Dressing Change Frequency on Surgical Wound Healing Following Primary Total Hip Arthroplasty","CAP-HIP","Inclusion Criteria:\n\nPatients scheduled for primary total hip arthroplasty (THA) Age ≥ 65 years Ability to provide informed consent Patients with closed surgical incision suitable for standard postoperative wound care\n\nExclusion Criteria:\n\nRevision hip arthroplasty Active infection at the time of surgery Immunosuppressive therapy or severe immunodeficiency Known allergy to dressing materials used in the study Severe peripheral vascular disease affecting wound healing Inability to comply with follow-up protocol","65 Years","95 Years",{"count":94,"type":22},90,[25],"Surgical wound complications following primary total hip arthroplasty remain a significant clinical challenge despite advances in wound care technologies. The optimal choice of dressing and frequency of dressing changes remain insufficiently investigated, particularly regarding their influence on wound healing and the wound microenvironment.\n\nThis prospective, randomized, controlled clinical trial aims to evaluate the impact of dressing type and dressing change frequency on surgical wound healing in patients undergoing primary total hip arthroplasty. Ninety patients will be allocated into three treatment groups receiving either a capillary-action dressing system (VACUTEX™) or standard dressings with different dressing change intervals.\n\nThe study will assess time to complete wound epithelialization, postoperative wound complications, pain intensity, wound temperature, exudate pH, length of hospital stay, and time to suture removal. In addition, the study will investigate the potential role of wound temperature and exudate pH as early indicators of impaired healing and postoperative complications.",[98,28],"Wound Healing Time",[100,101,102,103,104,105,106,107,108,109,110,111,112,113],"Wound Dressing","VACUTEX","Dressing Change Frequency","Primary Total Hip Arthroplasty","Surgical Wound","Wound Healing","Exudate pH","Wound Temperature","Postoperative Pain","Orthopedic Surgery","Nursing","Surgical Site Infection","Epithelialization","Wound Care","2026-06-12",{"date":35,"type":38},{"date":117,"type":22},"2026-05-25",{"date":119,"type":22},"2026-09-01",{"name":121,"class":45},"Clinical Center of Vojvodina",{"id":123,"slug":124,"hasResults":12,"nctId":125,"briefTitle":126,"officialTitle":127,"acronym":4,"eligibilityCriteria":128,"healthyVolunteers":12,"sex":17,"minAge":55,"maxAge":4,"enrollmentInfo":129,"targetDuration":4,"studyType":131,"phases":4,"briefSummary":132,"conditions":133,"keywords":138,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":145,"lastUpdatePostDateStruct":146,"startDateStruct":148,"completionDateStruct":150,"leadSponsor":152,"locationsCount":155},"100641958","post-market-clinical-follow-up-pmcf-study-evaluating-the-safety-and-efficacy-of-tpmed-primary-hip-prosthesis-system-100641958","NCT07651735","Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Primary Hip Prosthesis System","A Multicenter, Prospective, Observational, Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Primary Hip Prosthesis System","Inclusion Criteria:\n\n* Individuals aged 18 years and older,\n* Male or female participants,\n* Subjects who have undergone Primary Hip Arthroplasty (either total or partial) for any indication,\n* Subjects in whose surgical procedure the Tipmed™ Primary Hip Prosthesis System components were utilized.\n* Subjects who are not legally restricted (e.g., military personnel, convicts, or individuals under legal guardianship).\n* Subjects who have voluntarily signed the written Informed Consent Form (ICF).\n\nExclusion Criteria:\n\n* Subjects currently participating in any other interventional clinical trial.",{"count":130,"type":22},101,"OBSERVATIONAL","This is a multicenter, prospective, observational, post-market clinical follow-up (PMCF) study designed to evaluate the safety and clinical performance of the Tipmed™ Primary Hip Prosthesis System in adult subjects undergoing primary hip arthroplasty. The study aims to gather real-world clinical evidence on the 24-month post-operative safety profile, potential complications, and functional outcomes of the device during routine clinical practice.",[28,134,135,136,137],"Hemiarthroplasty","Osteoarthritis (OA) of the Hip","Femoral Neck Fractures","Joint Diseases",[139,140,141,142,143,144],"Hip Prosthesis","Total Hip Prosthesis","Partial Hip Prosthesis","Primary Hip Arthroplasty","Post-Market Clinical Follow-Up (PMCF)","Harris Hip Score (HHS)","2026-06-10",{"date":147,"type":38},"2026-06-16",{"date":149,"type":38},"2024-03-12",{"date":151,"type":22},"2029-03-31",{"name":153,"class":154},"TIPMED Medical Device Manufacturing Ltd. Co.","INDUSTRY",4,{"id":157,"slug":158,"hasResults":12,"nctId":159,"briefTitle":160,"officialTitle":161,"acronym":4,"eligibilityCriteria":162,"healthyVolunteers":12,"sex":17,"minAge":55,"maxAge":4,"enrollmentInfo":163,"targetDuration":4,"studyType":23,"phases":165,"briefSummary":167,"conditions":168,"keywords":171,"overallStatus":175,"whyStopped":4,"lastUpdateSubmitDate":176,"lastUpdatePostDateStruct":177,"startDateStruct":179,"completionDateStruct":181,"leadSponsor":183,"locationsCount":46},"100640961","phase-4-post-op-prednisone-and-glucose-monitoring-in-tka-100640961","NCT07630896","Post-op Prednisone and Glucose Monitoring in TKA","Postoperative Prednisone Regimen in TKA and Its Effect on Continuous Glucose Levels","Inclusion Criteria:\n\n* Undergoing Primary Unicompartmental Knee Arthroplasty or Total Hip Arthroplasty\n* Age 18 and above\n\nExclusion Criteria:\n\n* Steroid therapy\n* Narcotic use within past 3 months\n* History of corticosteroid intolerance\n* Pregnancy\n* Uncontrolled diabetes\n* Doesn't own smart phone\n\nDrop Criteria:\n\n\\- 2nd dose of IV dexamethasone",{"count":164,"type":22},104,[166],"PHASE4","This study compares the efficacy of a 5-day post-operative oral prednisone regimen (40 mg daily) with the standard intraoperative steroid regimen, focusing on pain, swelling, range of motion, opioid use, and glucose levels monitored continuously.",[169,170,28],"Osteoarthritis","Unicompartmental Knee Arthroplasty",[172,173,174],"Post-operative pain","Prednisone","Continuous Glucose Monitoring","NOT_YET_RECRUITING","2026-06-03",{"date":178,"type":38},"2026-06-05",{"date":180,"type":22},"2026-07-01",{"date":182,"type":22},"2028-03",{"name":184,"class":45},"Columbia University",{"id":186,"slug":187,"hasResults":12,"nctId":188,"briefTitle":189,"officialTitle":190,"acronym":4,"eligibilityCriteria":191,"healthyVolunteers":192,"sex":17,"minAge":55,"maxAge":19,"enrollmentInfo":193,"targetDuration":4,"studyType":23,"phases":195,"briefSummary":197,"conditions":198,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":215,"lastUpdatePostDateStruct":216,"startDateStruct":217,"completionDateStruct":219,"leadSponsor":221,"locationsCount":46},"100610370","phase-3-suzetrigine-in-total-hip-arthroplasty-100610370","NCT07226700","Suzetrigine in Total Hip Arthroplasty","A Randomized, Placebo-controlled, Double-blind Trial of Suzetrigine in Total Hip Arthroplasty","Inclusion Criteria:\n\n* Patients undergoing primary THA (posterior approach) with participating surgeons\n* Age 18 to 80 years old\n* Planned discharge to home\n* Planned use of neuraxial anesthesia\n* American Society of Anesthesiologists (ASA) Physical Status 1 - 3\n\nExclusion Criteria:\n\n* ASA greater than 3\n* Chronic opioid use (daily MME of greater than 30 mg for at least 3 months and within 1 month of surgery)\n* History of chronic pain syndromes or uncontrolled pain (i.e. complex regional pain syndrome, fibromyalgia, implanted spinal cord stimulator)\n* History of QT prolongation\n* Presence of automated implantable cardioverter defibrillator, pacemaker or cardiac resynchronization device\n* Evidence of misuse, aberrant use, or addiction to alcohol or an illicitly used drug of abuse, or had a positive test for drugs of abuse\n* Inability to comply with any component of the study protocol\n* Younger than 18 or greater than 80 years old at the time of enrollment\n* Patient already on Suzetrigine\n* Allergy or contraindication to Suzetrigine or excipients (eg moderate to severe liver disease\u002FChild Pugh B or C, use of strong CYP3 inhibitors or inducers)\n* Contraindications to neuraxial anesthesia or any other part of the study protocol\n* Participation in another investigational drug or device study\n* Pregnancy",true,{"count":194,"type":22},210,[196],"PHASE3","Total hip and knee joint replacements are among the most common and painful orthopedic procedures performed worldwide, often requiring intensive analgesia to support early ambulation and recovery. Despite widespread use of multimodal regimens, many patients still rely on opioids, which can cause sedation, nausea, constipation, and long-term dependency. Evaluating Suzetrigine in this high-need population may improve recovery trajectories, reduce opioid consumption, and support enhanced recovery protocols. Given the growing surgical volume and the emphasis on opioid-sparing strategies, rigorous investigation of Suzetrigine's efficacy in joint replacement is of high clinical value. In this study, patients undergoing primary total hip replacement will be randomized to receive either Suzetrigine or placebo for seven days, with the loading dose administered prior to surgery. The primary outcome is cumulative 48-hour opioid consumption in oral morphine equivalents starting from entry into the post-anesthesia care unit (PACU).",[28,199,200,201,202,203,204,205,206,207,208,209,210,211,212,213,214],"Total Hip Arthroplasty \\(THA\\)","Total Hip Replacement","Total Hip Replacement Surgery","Total Hip Replacements","Total Hip Replacement Arthroplasty","Suzetrigine","Pain Management","Pain","Nav 1.8","JOURNAVX","Opioid Cessation","Opioid Consumption, Postoperative","Multimodal Analgesia","Randomized Controlled Trial","Randomized Controlled Study","Randomized Controlled Trials","2026-06-02",{"date":176,"type":38},{"date":218,"type":38},"2025-11-03",{"date":220,"type":22},"2028-11-01",{"name":222,"class":45},"Hospital for Special Surgery, New York",{"id":224,"slug":225,"hasResults":12,"nctId":226,"briefTitle":227,"officialTitle":228,"acronym":4,"eligibilityCriteria":229,"healthyVolunteers":12,"sex":17,"minAge":55,"maxAge":4,"enrollmentInfo":230,"targetDuration":4,"studyType":23,"phases":232,"briefSummary":233,"conditions":234,"keywords":4,"overallStatus":175,"whyStopped":4,"lastUpdateSubmitDate":235,"lastUpdatePostDateStruct":236,"startDateStruct":238,"completionDateStruct":240,"leadSponsor":242,"locationsCount":4},"100640881","mfinity-be-pre-market-trial-100640881","NCT07616895","MFinity BE Pre-market Trial","Prospective Single-arm Clinical Study Assessing the Safety and Effectiveness of a Novel Femoral Stem for Total Hip Arthroplasty.","Inclusion Criteria:\n\n* Patients undergoing elective primary total hip arthroplasty for primary osteoarthritis, who are suitable for implantation of a cementless femoral stem according to the MFinity femoral stem Instructions for Use\n* Skeletally mature adult aged 18 years and older at the time of enrollment.\n* Ability to give informed consent.\n* Patient is informed of the conditions of the study and is willing to participate for the length of the prescribed follow-up period.\n\nExclusion Criteria:\n\n* Not meeting the inclusion criteria.\n* Active infection within the affected hip joint.\n* Previous total hip replacement or hip fusion of the affected hip joint.\n* Neuromuscular or neurosensory deficiency limiting the ability to evaluate the safety and effectiveness of the device.\n* Bone condition that may compromise the stability of the implant\n* Known allergy or hypersensitivity to the implant material\n* Immunologically suppressed, or receiving steroids in excess of physiologic dose requirements.\n* For women of childbearing potential\\*: a positive pregnancy test\n* Patients with severe osteoarthritis in the contralateral hip or other joints that may interfere with the assessment of study outcomes.\n* Patients who have previously participated in this clinical trial.\n\n  * a woman is considered of childbearing potential, i.e. fertile, following menarche and until becoming post-menopausal unless permanently sterile. A postmenopausal state is defined as no menses for 12 months without an alternative medical cause. Women using one of the following birth control methods are not considered of childbearing potential: combined (estrogen and progestogen containing) hormonal contraception associated with inhibition of ovulation (oral, intravaginal, or transdermal), progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, or implantable),intrauterine device (IUD), intrauterine hormone-releasing system (IUS), bilateral tubal occlusion, vasectomised partner, and sexual abstinence.",{"count":231,"type":22},95,[25],"The primary objective of this trial is to determine the implant survival at 1 year of follow up in a population of patients undergoing primary Total Hip Replacement with MFinity Collared Femoral stem and to test its non-inferiority compared to other cementless implant (as reported by the EPRD registry).",[28],"2026-05-27",{"date":237,"type":38},"2026-06-01",{"date":239,"type":22},"2026-06",{"date":241,"type":22},"2029-06",{"name":243,"class":154},"Medacta International SA",{"id":245,"slug":246,"hasResults":12,"nctId":247,"briefTitle":248,"officialTitle":249,"acronym":4,"eligibilityCriteria":250,"healthyVolunteers":12,"sex":17,"minAge":55,"maxAge":251,"enrollmentInfo":252,"targetDuration":4,"studyType":23,"phases":254,"briefSummary":255,"conditions":256,"keywords":4,"overallStatus":175,"whyStopped":4,"lastUpdateSubmitDate":258,"lastUpdatePostDateStruct":259,"startDateStruct":261,"completionDateStruct":263,"leadSponsor":265,"locationsCount":4},"100636341","effects-of-additional-high-intensity-pulsed-electromagnetic-field-hi-pemf-therapy-on-pain-and-physical-function-after-total-hip-replacement-100636341","NCT07564427","Effects of Additional High-Intensity Pulsed Electromagnetic Field (HI-PEMF) Therapy on Pain and Physical Function After Total Hip Replacement","Effects of Additional High-Intensity Pulsed Electromagnetic Field (HI-PEMF) Therapy on Pain and Physical Function After Total Hip Replacement: A Randomized Controlled Trial","Inclusion Criteria:\n\nA. Age 18 years or older.\n\nB. Patients who have undergone primary unilateral total hip arthroplasty due to hip osteoarthritis.\n\nC. Patients who, after postoperative evaluation by their surgeon, are advised to bear full weight within their tolerance.\n\nExclusion Criteria:\n\nA. Patients who have not undergone primary hip arthroplasty.\n\nB. Patients who are advised by their doctor to maintain non-weight-bearing or partial weight-bearing on the affected or unaffected side.\n\nC. History of neurological deficits (e.g., sensory abnormalities, stroke, spinal cord injury, Parkinson's disease, multiple sclerosis).\n\nD. Mini-Mental State Examination (MMSE) \\\u003C 24 (mild cognitive impairment).\n\nE. Berger's Balance Scale (BBS) \\\u003C 40 (higher risk of falls).\n\nF. Sensory abnormalities.\n\nG. Before or after this exercise training, if pain in other areas (e.g., degenerative pain in the knee or spine) prevents movement, or if the hip joint still experiences pain on a Visual Analogue Scale (VAS) score of 4 or higher even after taking pain medication.\n\nH. Known malignancy.\n\nI. Schizophrenia, bipolar disorder, or substance addiction (e.g., alcohol, drug).\n\nJ. Pregnant woman.\n\nK. Individuals with implanted stents, pacemakers, or those requiring treatment for arrhythmia.\n\nL. Wearing a hearing aid.","99 Years",{"count":253,"type":22},40,[25],"This study aims to verify whether high-intensity pulsed electromagnetic fields (HI-PEMF) can be effectively applied to postoperative total hip arthroplasty patients. Using pain and function as the primary assessment indicators, the study explores the effects of HI-PEMF on postoperative total hip arthroplasty to confirm its effectiveness in relieving pain and improving daily living functions. Simultaneously, it combines physical therapy with exercise training to simulate a clinical environment, comprehensively understanding the feasibility of future clinical applications of magnetic field therapy. It is hoped that by exploring the potential benefits of magnetic field intervention in improving the postoperative condition of these high-needs patients, new clinical evidence can be provided for postoperative management.",[28,257],"Magnetotherapy","2026-05-10",{"date":260,"type":38},"2026-05-13",{"date":262,"type":22},"2026-04-28",{"date":264,"type":22},"2027-07-30",{"name":266,"class":45},"National Taiwan University Hospital",{"id":268,"slug":269,"hasResults":12,"nctId":270,"briefTitle":271,"officialTitle":272,"acronym":4,"eligibilityCriteria":273,"healthyVolunteers":12,"sex":17,"minAge":55,"maxAge":251,"enrollmentInfo":274,"targetDuration":4,"studyType":23,"phases":275,"briefSummary":276,"conditions":277,"keywords":282,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":285,"lastUpdatePostDateStruct":286,"startDateStruct":288,"completionDateStruct":290,"leadSponsor":292,"locationsCount":46},"100626579","binaural-beats-for-postoperative-pain-and-anxiety-reduction-100626579","NCT07437469","Binaural Beats for Postoperative Pain and Anxiety Reduction","Binaural Beats vs Music of Choice for Early Postoperative Pain After Ambulatory Total Knee and Total Hip Arthroplasty: A Randomized Controlled Trial","Inclusion Criteria:\n\n* American Society of Anesthesiologists Physical Status Classification System (ASA) 1-3\n* Spinal anesthesia\n* Patients receiving nerve-block in Post-Anesthesia Care Unit (PACU)\n* Primary total hip or total knee arthroplasty\n\nExclusion Criteria:\n\n* Moderate-severe hearing impairment or use of hearing aids\n* History of significant tinnitus, active delirium, chronic high-dose opioid therapy (\\>60 MME\u002Fday baseline)\n* Major psychiatric pathology\n* General anesthesia",{"count":21,"type":22},[25],"To deliver a 30-minute binaural beats audio intervention in PACU and collect pain and anxiety outcomes immediately following surgery, and 4 hours following surgery completion in adults undergoing ambulatory total knee arthroplasty and total hip arthroplasty (TKA and THA).",[68,67,278,279,280,28,63,281,200],"Anxiety","Binaural Beats","Music Exposure","Total Knee Replacement",[67,68,283,284,278,206,279,280],"Total hip arthroplasty","Total knee arthroplasty","2026-04-29",{"date":287,"type":38},"2026-04-30",{"date":289,"type":38},"2026-03-09",{"date":291,"type":22},"2026-08-30",{"name":293,"class":45},"University of Miami",{"id":295,"slug":296,"hasResults":12,"nctId":297,"briefTitle":298,"officialTitle":299,"acronym":4,"eligibilityCriteria":300,"healthyVolunteers":12,"sex":17,"minAge":55,"maxAge":4,"enrollmentInfo":301,"targetDuration":4,"studyType":23,"phases":303,"briefSummary":304,"conditions":305,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":285,"lastUpdatePostDateStruct":310,"startDateStruct":312,"completionDateStruct":314,"leadSponsor":316,"locationsCount":46},"100590197","iliopsoas-ipb-and-pericapsular-nerve-group-peng-blocks-comparison-on-analgesia-and-recovery-after-total-hip-arthroplasty-100590197","NCT06964282","Iliopsoas (IPB) and Pericapsular Nerve Group (PENG) Blocks Comparison on Analgesia and Recovery After Total Hip Arthroplasty","Comparison Between Iliopsoas Block (IPB) and Pericapsular Nerve Group (PENG) Block on Postoperative Analgesia and Functional Recovery After Total Hip Arthroplasty Surgery: a Double-blinded Randomized Clinical Trial","Inclusion Criteria:\n\nAdult patients (age \\>18 years) ASA physical status classification I-III Scheduled for elective posterior approach total hip arthroplasty (THA) under spinal anesthesia\n\nExclusion Criteria:\n\nPregnancy (confirmed by beta-HCG test if applicable) Known peripheral neuropathy or major neurological disease Chronic pain syndromes or long-term opioid use (\\>20 mg oral morphine equivalents\u002Fday) Severe hepatic or renal insufficiency Allergy to local anesthetics Major coagulopathies Vulnerable patients (e.g., minors, legally protected individuals)",{"count":302,"type":22},118,[25],"Background:\n\nIn recent years, regional anesthesia has become more popular because it can reduce pain and the need for strong pain medications like morphine. For hip surgery, the PENG block is already known to be effective. A newer method, called the iliopsoas plane block (IPB), is very similar and has also shown good results in hip arthroscopy. However, these two techniques have never been directly compared in patients undergoing hip replacement surgery using the posterior approach.\n\nGoal:\n\nThis study aims to see if the IPB is just as effective as the PENG block for controlling pain and helping patients recover well after hip replacement surgery.\n\nMethod:\n\n118 adult patients scheduled for hip replacement under spinal anesthesia will be randomly assigned to receive either: IPB: 7 ml of Ropivacaine 7.5 mg\u002Fml PENG: 14 ml of Ropivacaine 3.75 mg\u002Fml Both injections are given under ultrasound guidance 30 minutes before spinal anesthesia. Neither the patient, the surgeon, nor the data collector will know which technique was used.\n\nPost-Surgery Care:\n\nAll patients will receive standard pain relief, including:\n\nParacetamol every 6 hours Etoricoxib once a day Morphine via a patient-controlled pump for 48 hours\n\nMain Outcome Measured:\n\nThe primary goal is to compare pain during movement 6 hours after surgery, using a pain scale from 0 (no pain) to 10 (worst pain). The study will consider the two blocks equivalent if the difference in average pain scores is less than 1 point.\n\nOther Outcomes:\n\nTotal morphine used in 48 hours Pain scores at rest and during movement at various time points Walking ability (2- and 6-minute walk tests, and timed-up-and-go test) Quality of recovery (using the QoR-15 questionnaire) Side effects of morphine Patient satisfaction Length of hospital stay\n\nSafety:\n\nBoth techniques are safe and already used in clinical practice. Ultrasound guidance minimizes risks like nerve injury, bleeding, or infection.\n\nConclusion:\n\nIf the IPB is shown to be as effective as the PENG block, both can be considered reliable options for pain control and early recovery after hip replacement surgery.",[28,306,307,308,309],"Postoperative Pain Management","Peripheral Nerve Blocks","PENG Block","Iliopsoas Nerve Block",{"date":311,"type":38},"2026-05-06",{"date":313,"type":38},"2025-10-01",{"date":315,"type":22},"2026-10-10",{"name":317,"class":45},"University of Liege",{"id":319,"slug":320,"hasResults":12,"nctId":321,"briefTitle":322,"officialTitle":323,"acronym":4,"eligibilityCriteria":324,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":325,"enrollmentInfo":326,"targetDuration":4,"studyType":23,"phases":328,"briefSummary":329,"conditions":330,"keywords":331,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":334,"lastUpdatePostDateStruct":335,"startDateStruct":337,"completionDateStruct":339,"leadSponsor":341,"locationsCount":46},"100635281","early-rehabilitation-after-total-hip-arthroplasty-100635281","NCT07550647","Early Rehabilitation After Total Hip Arthroplasty","Effect of Early Rehabilitation on Functional Recovery After Total Hip Arthroplasty: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Patients scheduled for unilateral total hip arthroplasty due to osteoarthritis or developmental dysplasia of the hip (DDH)\n* Aged between 50 and 75 years\n* Willing and able to participate in all follow-up assessments\n* Able to comply with assessment procedures\n* Able to meet the requirements of telerehabilitation\n* Undergoing surgery with a standardized surgical protocol\n\nExclusion Criteria:\n\n* Previous history of total hip arthroplasty on either side\n* Planned revision total hip arthroplasty\n* Severe osteoarthritis in the contralateral hip\n* Presence of severe acute metabolic, neuromuscular, or cardiovascular disease\n* History of active malignancy\n* Presence of respiratory infection\n* Concomitant orthopedic conditions (e.g., lower extremity fractures, severe hip\u002Fknee deformities, lumbar or sacroiliac dysfunction)\n* Body mass index \\>35\n* Occurrence of postoperative complications (e.g., prosthetic infection, thromboembolic events, or conditions requiring reoperation)","75 Years",{"count":327,"type":22},52,[25],"This study aims to investigate the effects of an early postoperative rehabilitation program combined with neuromuscular electrical stimulation (NMES) and telerehabilitation on functional recovery in patients undergoing total hip arthroplasty (THA).\n\nIn the early postoperative period, patients commonly experience muscle weakness, impaired gait, and functional limitations that may delay recovery. Early rehabilitation has been shown to improve functional outcomes, while NMES may enhance muscle activation, particularly in hip abductor muscles. Additionally, telerehabilitation may support continuity of care following discharge by enabling supervised home-based exercise.\n\nIn this prospective study, participants will be assigned to either an intervention group receiving early physiotherapy combined with NMES and telerehabilitation, or a control group receiving standard postoperative care. Functional outcomes, gait parameters, quality of life, and muscle-related changes will be evaluated at predefined time points.",[28],[332,333],"Rehabilitation","Total Hip Arthtoplasty","2026-04-19",{"date":336,"type":38},"2026-04-24",{"date":338,"type":22},"2026-04",{"date":340,"type":22},"2027-10",{"name":342,"class":45},"Muğla Sıtkı Koçman University",{"id":344,"slug":345,"hasResults":12,"nctId":346,"briefTitle":347,"officialTitle":347,"acronym":348,"eligibilityCriteria":349,"healthyVolunteers":12,"sex":17,"minAge":55,"maxAge":4,"enrollmentInfo":350,"targetDuration":4,"studyType":131,"phases":4,"briefSummary":352,"conditions":353,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":354,"lastUpdatePostDateStruct":355,"startDateStruct":357,"completionDateStruct":359,"leadSponsor":361,"locationsCount":363},"100586591","clinical-performance-of-xpeo-e-liner-in-serf-dual-mobility-cups-100586591","NCT06917365","Clinical Performance of XPEO-E Liner in SERF Dual-mobility Cups","2024-01-XPEO-E","Inclusion Criteria:\n\n* Male or female adults.\n* Patient that needs to be implanted with a SERF total hip prosthesis.\n* Patient responding to IFU requirement.\n* Patient affiliated to French social security.\n* Patient who has provided a dated and signed informed consent form.\n\nExclusion Criteria:\n\n* Patient protected by a French legal measure (under legal protection, guardianship or curatorship).\n* Patient unable of expressing consent, according to the investigator.\n* Patient deprived of liberty or hospitalized against his consent.\n* Pregnant or breastfeeding patient.\n* Patient presenting a contraindication to the implantation of medical devices according to the instructions for use.\n* Patient with a contraindication to radiographic follow-up.\n* Patient not being, a priori, capable of respecting the schedule of follow-up visits, according to the investigator.\n* Patient unable to complete a self-questionnaire, according to the investigator.",{"count":351,"type":22},500,"XPEO-E liner is CE marked under MDD 93\u002F42\u002FCEE by equivalency with CI E liner. No pertaining data on XPEO-E liner is yet available. However, clinical evaluation concludes on a reaching of performance and safety and compliance with essential requirements. This study intends to collect data on XPEO-E in order to allow a transit to MDR 2017\u002F745 (EU).\n\nXPEO-E liner is intended to be used with NOVAE cups and SERF femoral heads and Stems. XPEO-E liner will be used according to their CE marking. These devices are intended for hip replacements with the aim of improving quality of life and reducing pain by replacing a damaged joint.\n\nThe follow-up visits are established according to the current practice. Additional procedure will only consist on questionnaires that will be filled by the patient and\u002For the surgeons.",[28],"2026-04-09",{"date":356,"type":38},"2026-04-13",{"date":358,"type":38},"2025-10-27",{"date":360,"type":22},"2032-03-31",{"name":362,"class":154},"Societe dEtude, de Recherche et de Fabrication",5,{"id":365,"slug":366,"hasResults":12,"nctId":367,"briefTitle":368,"officialTitle":369,"acronym":4,"eligibilityCriteria":370,"healthyVolunteers":12,"sex":17,"minAge":371,"maxAge":4,"enrollmentInfo":372,"targetDuration":4,"studyType":23,"phases":374,"briefSummary":375,"conditions":376,"keywords":378,"overallStatus":175,"whyStopped":4,"lastUpdateSubmitDate":387,"lastUpdatePostDateStruct":388,"startDateStruct":390,"completionDateStruct":391,"leadSponsor":393,"locationsCount":395},"100631818","ai-based-rehabilitation-for-hip-and-knee-surgery-patients-100631818","NCT07505628","AI-based Rehabilitation for Hip and Knee Surgery Patients","Evaluation of the Efficacy and Safety of AI-based Rehabilitation Exercise After Hip and Knee Arthroplasty","Inclusion Criteria:\n\n* Adult patients aged 19 years or older.\n* Patients scheduled to undergo hip or knee arthroplasty at Gangnam Severance Hospital or affiliated hospitals of Chung-Ang University Medical Center (Chung-Ang University Hospital, Gwangmyeong Hospital, Hyundai Hospital).\n* Patients with a preoperative Functional Ambulatory Category (FAC) stage of 4 or 5 (For hip fracture cases, pre-fracture FAC stage will be considered).\n* Patients capable of downloading and using mobile applications on smart devices (smartphones or tablets) independently without researcher assistance.\n* Patients who fully understand the study's purpose and procedures and have voluntarily signed the informed consent form.\n\nExclusion Criteria:\n\n* Individuals unable to perform exercises due to severe musculoskeletal pain.\n* Individuals with severe dizziness or poor vision that prevents them from following exercise videos provided by the digital treatment.\n* Individuals with visual impairment that causes difficulty in recognizing the monitor\u002Fdevice screen.\n* Individuals requiring long-term inpatient treatment due to unstable vital signs.\n* Individuals with partial or total lower-limb amputation due to trauma, disease, or congenital defects.\n* Individuals classified as vulnerable subjects (as defined by clinical research ethics guidelines).\n* Any other individuals deemed ineligible for participation at the discretion of the principal investigator.","19 Years",{"count":373,"type":22},106,[25],"This study aims to evaluate the efficacy and safety of an AI-based home rehabilitation application (\"Exersite Rehab\") for patients who have undergone hip or knee arthroplasty(Total Knee Arthroplasty (TKA), Total Hip Arthroplasty (THA) or hip fracture surgery). Following surgery, effective rehabilitation is crucial for functional recovery; however, many patients face barriers to consistent in-hospital exercise. This interventional study divides participants into two groups to compare outcomes. The experimental group will perform a 12-week home-based rehabilitation program guided by an AI application that provides real-time posture correction and monitoring. In contrast, the control group will perform the same exercise protocol using traditional printed educational brochures.The primary objective is to determine if the AI-based digital healthcare solution significantly improves physical function, measured by the Functional Ambulatory Category(FAC), compared to conventional methods. Secondary outcomes including pain levels(Visual Analog Scale (VAS)) and joint-specific functional scores (Knee Society Score (KSS), Harris Hip Score (HHS)) will also be assessed over the 12-week period.",[63,28,377],"Hip Fracture Surgery",[379,68,67,380,381,382,383,384,385,386],"Arthroplasty","Hip Fracture","Digital Therapeutics","AI Rehabilitation","Mobile Application","Home-based Exercise","Remote Monitoring","Physical Function","2026-03-26",{"date":389,"type":38},"2026-04-01",{"date":289,"type":22},{"date":392,"type":22},"2028-12-31",{"name":394,"class":45},"Gangnam Severance Hospital",2,{"id":397,"slug":398,"hasResults":12,"nctId":399,"briefTitle":400,"officialTitle":401,"acronym":4,"eligibilityCriteria":402,"healthyVolunteers":12,"sex":17,"minAge":55,"maxAge":4,"enrollmentInfo":403,"targetDuration":4,"studyType":23,"phases":404,"briefSummary":405,"conditions":406,"keywords":407,"overallStatus":175,"whyStopped":4,"lastUpdateSubmitDate":412,"lastUpdatePostDateStruct":413,"startDateStruct":415,"completionDateStruct":417,"leadSponsor":419,"locationsCount":4},"100631558","peng-block-with-or-without-ppd-block-for-postoperative-analgesia-after-total-hip-arthroplasty-100631558","NCT07502248","PENG Block With or Without PPD Block for Postoperative Analgesia After Total Hip Arthroplasty","Comparison of the Efficacy of Pericapsular Nerve Group (PENG) Block Versus PENG Block Added to Posterior Pericapsular Deep Gluteal (PPD) Block for Postoperative Analgesia in Total Hip Arthroplasty","Inclusion Criteria:\n\n* Adults aged 18 years and older\n* American Society of Anesthesiologists (ASA) physical status I-III\n* Scheduled for elective primary total hip arthroplasty under spinal anesthesia\n* Able to provide written informed consent\n\nExclusion Criteria:\n\n* ASA physical status IV or V\n* Serious concomitant cardiac, respiratory, hepatic, or renal disease\n* Known neuropsychiatric disorder\n* Cognitive impairment preventing understanding or response to the Numeric Rating Scale (NRS)\n* Coagulopathy\n* Local anesthetic allergy\n* Infection or scar at the block site\n* Failed block\n* Refusal to participate\n* Signs of local anesthetic systemic toxicity after block\n* Patients in the PENG plus PPD group who would be exposed to a total local anesthetic dose above 3 mg\u002Fkg in patients weighing less than 50 kg\n* Revision total hip arthroplasty\n* Total hip arthroplasty planned for fracture",{"count":253,"type":22},[25],"This single-center, prospective, randomized controlled clinical trial aims to compare the postoperative analgesic efficacy of PENG block with or without posterior pericapsular deep gluteal block in adult patients undergoing elective primary total hip arthroplasty under spinal anesthesia. Total hip arthroplasty is commonly associated with moderate to severe postoperative pain. Although PENG block provides analgesia for the anterior hip capsule, some patients may still experience pain originating from the posterior capsule. The addition of PPD block may improve analgesia by targeting posterior articular branches. Participants will be randomized into two groups: one group will receive PENG block, and the other group will receive PENG plus PPD block. Postoperative pain will be assessed using the Numeric Rating Scale (NRS). The study will compare postoperative pain scores and other analgesia-related outcomes between groups.",[108,28],[408,409,410,411],"PENG block","PPD block","Postoperative analgesia","Numeric Rating Scale","2026-03-25",{"date":414,"type":38},"2026-03-30",{"date":416,"type":22},"2026-04-05",{"date":418,"type":22},"2027-06-05",{"name":420,"class":45},"Kirsehir Ahi Evran Universitesi",{"id":422,"slug":423,"hasResults":12,"nctId":424,"briefTitle":425,"officialTitle":426,"acronym":427,"eligibilityCriteria":428,"healthyVolunteers":12,"sex":17,"minAge":55,"maxAge":19,"enrollmentInfo":429,"targetDuration":4,"studyType":23,"phases":431,"briefSummary":432,"conditions":433,"keywords":434,"overallStatus":175,"whyStopped":4,"lastUpdateSubmitDate":438,"lastUpdatePostDateStruct":439,"startDateStruct":440,"completionDateStruct":442,"leadSponsor":444,"locationsCount":395},"100630787","comparison-of-blood-loss-between-cemented-and-uncemented-femoral-stems-in-anterior-total-hip-arthroplasty-100630787","NCT07492212","Comparison of Blood Loss Between Cemented and Uncemented Femoral Stems in Anterior Total Hip Arthroplasty","Comparison of Blood Loss Between Cemented and Uncemented Femoral Stems in Anterior Total Hip Arthroplasty - A Prospective, Randomized, Multicenter Study","FEMFIX","Inclusion Criteria:\n\n* patient needed a total hip arthroplasty\n\nExclusion Criteria:\n\n* Previous surgery on the affected hip\n* Preoperative anemia\n* Femoral neck fracture\n* Patient with a contraindication to tranexamic acid\n* Pregnant or breastfeeding patient",{"count":430,"type":22},86,[25],"Total hip arthroplasty (THA) yields excellent results. To perform the procedure, the surgeon must make certain decisions, including the choice of fixation method for the femoral implant.\n\nThis surgery, considered to carry a risk of bleeding, therefore exposes the patient :\n\n* to complications: heart attacks, strokes...\n* to mortality\n* to transfusion: specific risks, cost, length of hospital stay\n* to anemia: fatigue, longer recovery time The influence of the femoral fixation method on bleeding and blood loss is often debated, but the literature on the subject is very limited.\n\nOur hypothesis is that the method of femoral fixation in THA influences bleeding and blood loss, with a benefit for cemented fixations.",[28],[435,436,437],"hip arthroplasty","implant","blood loss","2026-03-19",{"date":412,"type":38},{"date":441,"type":22},"2026-04-15",{"date":443,"type":22},"2028-06-30",{"name":445,"class":45},"Clinique du Pré",{"id":447,"slug":448,"hasResults":12,"nctId":449,"briefTitle":450,"officialTitle":451,"acronym":452,"eligibilityCriteria":453,"healthyVolunteers":12,"sex":17,"minAge":91,"maxAge":454,"enrollmentInfo":455,"targetDuration":4,"studyType":23,"phases":457,"briefSummary":458,"conditions":459,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":462,"lastUpdatePostDateStruct":463,"startDateStruct":465,"completionDateStruct":467,"leadSponsor":469,"locationsCount":395},"100623121","cognitive-and-physical-recovery-after-hip-fracture-in-frail-patients-using-digital-rehabilitation-technology-100623121","NCT07392515","Cognitive and Physical Recovery After Hip Fracture in Frail Patients Using Digital Rehabilitation Technology","Cognitive and Motor Recovery in Frail Patients With Hip Fracture: Effectiveness of Digital Technology-Assisted Rehabilitation and Analysis of Biomolecular Mechanisms","FEWF","Inclusion Criteria:\n\n* Age between 65 and 89 years\n* Patients who have undergone one of the following surgical treatments specifically for proximal femur fracture including Total hip arthroplasty (total hip replacement), Partial hip arthroplasty (hemiarthroplasty), Intramedullary nailing\n* Time since surgery not exceeding 15 days\n* Clinical stability\n* Patients admitted to the rehabilitation wards of the centers involved in the study and therefore eligible for rehabilitative therapy.\n\nExclusion Criteria:\n\n* Age \\> 90 years\n* Age \\\u003C 65 years\n* Refusal to sign the informed consent form\n* Behavioral or cognitive disorders limiting compliance with the rehabilitative treatment\n* Presence of mechanical instability of the implanted surgical device\n* Clinical instability (e.g., sepsis, severe anemia, cardiorespiratory failure) or pre-existing comorbidities affecting ambulation (neurological diseases or chronic pre-existing disabilities)\n* Concomitant presence of other fractures that prevent the possibility of carrying out a rehabilitative treatment\n* Severe visual impairments not correctable with lenses that prevent the patient from performing the treatment using digital tools\n* Pre-existing motor disability prior to the femur fracture due to other systemic diseases (e.g., advanced-stage neurodegenerative diseases, severe heart failure)\n* Conditions contraindicating the use of sensors (pacemaker, epilepsy, skin lesions, open wounds, and severe allergies in areas of contact with the devices).","89 Years",{"count":456,"type":22},30,[25],"The aim of this study is to evaluate whether integrating a technology-based rehabilitation approach with conventional therapies in the rehabilitation of patients with proximal femoral fracture may be advantageous compared with conventional therapy alone. Specifically, the objective is to assess whether the addition of technology-assisted rehabilitation can improve cognitive function, in addition to motor function and overall abilities, compared with conventional rehabilitation alone. Furthermore, the study intends to explore the feasibility of implementing technology-assisted rehabilitation as a stable and routine component of everyday clinical practice, also considering the perspective of healthcare professionals.",[460,461,28],"Fracture Femur","Hip Arthroplasty Replacement","2026-03-11",{"date":464,"type":38},"2026-03-13",{"date":466,"type":38},"2026-02-09",{"date":468,"type":22},"2026-07-31",{"name":470,"class":45},"C.O.T. Cure Ortopediche Traumatologiche S.p.A.",{"id":472,"slug":473,"hasResults":12,"nctId":474,"briefTitle":475,"officialTitle":475,"acronym":4,"eligibilityCriteria":476,"healthyVolunteers":12,"sex":17,"minAge":55,"maxAge":4,"enrollmentInfo":477,"targetDuration":4,"studyType":23,"phases":479,"briefSummary":480,"conditions":481,"keywords":482,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":486,"lastUpdatePostDateStruct":487,"startDateStruct":489,"completionDateStruct":491,"leadSponsor":493,"locationsCount":46},"100627812","evaluating-the-efficacy-of-the-psoas-sheath-block-for-post-operative-analgesia-following-hip-arthroplasty-100627812","NCT07453498","Evaluating the Efficacy of the Psoas Sheath Block for Post Operative Analgesia Following Hip Arthroplasty","Inclusion Criteria:\n\n* Participants aged \\>18\n* Patients scheduled to undergo elective unilateral total hip replacement (THR) surgery.\n* Patients who agree to receive regional anaesthetic blocks as part of their post-operative pain management.\n* Physical Status: ASA (American Society of Anesthesiologists) physical status classification I-III.\n* Patients who are willing and able to provide informed consent, demonstrating an understanding of the trial's purpose, methods, and potential risks.\n* Patients who are willing to comply with assessments post-surgery\n\nExclusion Criteria:\n\n* Allergy to Study Medications\n* History of chronic opioid use (\\>50mg of oral morphine equivalents per day.\n* Any neurological condition affecting the lower extremities (e.g., peripheral neuropathy, radiculopathy) that could interfere with pain assessment or recovery evaluation.\n* Infection at Injection Site\n* Coagulopathy or Anticoagulant Use: Patients with coagulopathy (INR \\>1.5) or who are on anticoagulant therapy that cannot be safely discontinued for the block procedure.\n* Severe Respiratory or Cardiovascular Disease: Any severe respiratory or cardiovascular disease (e.g., severe chronic obstructive pulmonary disease, heart failure) that may increase perioperative risk and complicate recovery.\n* Cognitive impairment or conditions (e.g., dementia with MMSE \\\u003C24) that would prevent reliable pain reporting or compliance with post-operative assessments",{"count":478,"type":22},130,[25],"This study will be a single-centre, assessor-blind, randomised controlled trial to compare the efficacy of the psoas sheath block (experimental group) with the suprainguinal fascia iliaca plane block (control group) in patients undergoing total hip arthroplasty\n\nParticipants will be randomly assigned to one of two groups (psoas sheath block or Fascia Iliaca block) using a computer-generated random number sequence. The allocation will be concealed in opaque, sealed envelopes.\n\nThe assessor will be blinded to the group allocation to ensure unbiased outcome assessment",[28],[483,484,485],"Total Hip Arthroplasty","Psoas Sheath Block","Regional anaesthesia","2026-03-02",{"date":488,"type":38},"2026-03-06",{"date":490,"type":38},"2025-11-18",{"date":492,"type":22},"2027-11-18",{"name":494,"class":45},"University College Hospital Galway",{"id":496,"slug":497,"hasResults":12,"nctId":498,"briefTitle":499,"officialTitle":500,"acronym":4,"eligibilityCriteria":501,"healthyVolunteers":12,"sex":17,"minAge":55,"maxAge":19,"enrollmentInfo":502,"targetDuration":4,"studyType":23,"phases":504,"briefSummary":505,"conditions":506,"keywords":508,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":510,"lastUpdatePostDateStruct":511,"startDateStruct":513,"completionDateStruct":515,"leadSponsor":516,"locationsCount":46},"100625832","effect-of-cognitive-behavioral-therapy-on-kinesiophobia-and-functional-outcomes-after-total-hip-arthroplasty-100625832","NCT07427758","Effect of Cognitive Behavioral Therapy on Kinesiophobia and Functional Outcomes After Total Hip Arthroplasty.","Effect of Cognitive Behavioral Therapy on Kinesiophobia and Clinical Outcomes After Total Hip Arthroplasty: A Randomized Controlled Trial.","Inclusion Criteria:\n\n((1) postoperative unilateral THA for the first time; (2) at least primary education; (3) ≥18 years of age ; (4) voluntary participation and close cooperation with the care plan; and (5) agreement to continue the intervention and the six-month follow-up after discharge,(6) high level of kinesiophobia on Tampa Scale of Kinesiophobia(TSK), (7)medically stable and cleared by their orthopedic surgeon.\n\nExclusion Criteria:\n\n(1) revision surgery, (2) severe osteoarthritis in the contralateral hip, (3) severe acute metabolic neuromuscular and cardiovascular disease, (4) body mass index above 40, (5) presence of malignancy, any other orthopedic or neurologic problem that might affect treatment and assessments, (6) any condition that might interfere with communication, (7) or lack of cooperation during the study.(9) Individuals with cognitive disorder,(10) individuals with any psychological disease or disorder,(10) Had previously participated in a CBT intervention,(11) pregnancy.",{"count":503,"type":22},100,[25],"The goal of this clinical trial study is to evaluate the effectiveness of cognitive behavioral therapy in reducing kinesiophobia and improving Clinical outcomes in postoperative patients following total hip arthroplasty The main question it aims to answer is:\n\nDoes the addition of cognitive behavioral therapy to standard physical therapy rehabilitation exercise reduce kinesiophobia and pain while improving functional mobility and quality of life in postoperative patients after total hip arthroplasty ? Participants will be divided into two groups to be compared: the first group (Control group) will only receive standard physical therapy rehabilitation exercises , consistent with routine post-total hip arthroplasty care, while the second group ( experimental group) will receive the same program in addition to cognitive behavioral therapy.",[28,507],"Kinesiophobia (Fear of Movement)",[483,509],"Kinesiophobia (fear of movement)","2026-02-17",{"date":512,"type":38},"2026-02-23",{"date":514,"type":38},"2026-02-01",{"date":119,"type":22},{"name":517,"class":45},"Cairo University",{"id":519,"slug":520,"hasResults":12,"nctId":521,"briefTitle":522,"officialTitle":522,"acronym":4,"eligibilityCriteria":523,"healthyVolunteers":12,"sex":17,"minAge":55,"maxAge":4,"enrollmentInfo":524,"targetDuration":4,"studyType":131,"phases":4,"briefSummary":526,"conditions":527,"keywords":531,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":535,"lastUpdatePostDateStruct":536,"startDateStruct":538,"completionDateStruct":540,"leadSponsor":542,"locationsCount":46},"100619684","molecular-mechanisms-underlying-hip-and-knee-osteoarthritis-in-patients-undergoing-primary-elective-arthroplasty-100619684","NCT07347821","Molecular Mechanisms Underlying Hip and Knee Osteoarthritis in Patients Undergoing Primary Elective Arthroplasty","Inclusion Criteria:\n\n* 18 years old and more\n* patient qualified for primary TKA or primary THA\n* patient diagnosed with hip or knee osteoarthritis\n* a complete set of tissues of good quality and volume is available\n* does not meet the exclusion criteria.\n\nExclusion Criteria:\n\n* lack of written consent to participate in the study or surgery\n* any private or professional relationship with the Investigators\n* genetic connective tissue diseases (e.g., Ehlers-Danlos syndrome and others)\n* genetic metabolic diseases (e.g., gout and others)\n* genetic diseases affecting the anatomy of the operated joint (e.g., dysplasia and others)\n* previous surgeries altering the anatomy of the examined joint (e.g., periacetabular osteotomy, unicompartmental endoprosthesis, and others)\n* patients undergoing revision after THA\u002FTKA\n* autoimmune diseases in the patient's medical history\n* traumatic injury to the hip or knee joint\n* previous participation in the study.",{"count":525,"type":22},1000,"The aim of this observational study is to determine content of rare metals and other elements, along with the levels of selected immunological parameters, in the tissue of the hip or knee joint in the course of degenerative diseases. Determining potential disturbances in the levels or functions of these parameters may in the future contribute to improving treatment - for example, through supplementation of deficient metals or modulation at the immunological level. The main question it aims to answer is:\n\nAre selected rare metals, trace elements and other selected immunological parameters lowered in the tissue of the hip or knee joint as well as in serum in the course of osteoarthritis?",[28,528,529,530],"Total Knee Arthroplasty (TKA)","Hip Osteoarthritis","Knee Osteoarthristis",[281,200,532,169,533,534],"Trace Elements","Cytokines","Oxidative Stress","2026-01-08",{"date":537,"type":38},"2026-01-16",{"date":539,"type":38},"2025-11-22",{"date":541,"type":22},"2028-12",{"name":543,"class":45},"Medical University of Warsaw",{"id":545,"slug":546,"hasResults":12,"nctId":547,"briefTitle":548,"officialTitle":549,"acronym":4,"eligibilityCriteria":550,"healthyVolunteers":12,"sex":17,"minAge":55,"maxAge":4,"enrollmentInfo":551,"targetDuration":4,"studyType":23,"phases":552,"briefSummary":553,"conditions":554,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":555,"lastUpdatePostDateStruct":556,"startDateStruct":558,"completionDateStruct":560,"leadSponsor":562,"locationsCount":46},"100596259","impact-of-rehabilitation-therapy-using-strength-and-blood-flow-restriction-training-on-muscular-fitness-and-regeneration-after-elective-hip-replacement-100596259","NCT07043127","Impact of Rehabilitation Therapy Using Strength and Blood Flow Restriction Training on Muscular Fitness and Regeneration After Elective Hip Replacement","Clinical Randomized Trial of the Influence of Rehabilitation Therapy Using Strength and Blood Flow Restriction Training on Muscular Fitness and Regeneration After Elective Hip Replacement","Inclusion Criteria:\n\n* Ability for Rehabilitation\n* Total Hip Arthroplasty Surgery during the last 4 Weeks\n\nExclusion Criteria:\n\n* Sickle Cell Anemia\n* Iatrogenic changes in the vessels of the lower Extremity (e.g. Stents)\n* Open Wounds or Infections of the lower Extremity",{"count":456,"type":22},[25],"In the present project, the framework conditions of outpatient rehabilitation at the Bonn Center for Outpatient Rehabilitation will now be used to prove whether sports science-controlled strength and BFR training has a similar effect in the postoperative rehabilitation phase. Strength and BFR training in medical training therapy complements daily exercise therapy in order to ensure implementation in the guideline-based rehabilitation process. . The interventions are carried out as part of the exercise therapy units in outpatient rehabilitation ETM01 following the RTS hip and knee TEP basis KTL 2020.",[28],"2025-12-05",{"date":557,"type":38},"2025-12-08",{"date":559,"type":38},"2025-01-01",{"date":561,"type":22},"2026-12-31",{"name":563,"class":45},"University Hospital, Bonn",{"id":565,"slug":566,"hasResults":12,"nctId":567,"briefTitle":568,"officialTitle":569,"acronym":4,"eligibilityCriteria":570,"healthyVolunteers":12,"sex":17,"minAge":55,"maxAge":571,"enrollmentInfo":572,"targetDuration":4,"studyType":23,"phases":574,"briefSummary":575,"conditions":576,"keywords":577,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":580,"lastUpdatePostDateStruct":581,"startDateStruct":583,"completionDateStruct":585,"leadSponsor":587,"locationsCount":46},"100611467","lumbal-erector-spinae-plane-block-for-pain-management-after-total-hip-arthroplasty-100611467","NCT07240961","Lumbal Erector Spinae Plane Block for Pain Management After Total Hip Arthroplasty","Ultrasound-Guided Lumbal Erector Spinae Plane Block on Postoperative Pain Management After Total Hip Arthroplasty","Inclusion Criteria:\n\n* primary total hip arthroplasty with lateral approach and under general anesthesia .\n\nExclusion Criteria:\n\n* • Contraindication or refusal to regional anesthesia\n\n  * Contraindication to non-steroidal anti-inflammatory (NSAID's)\n  * Allergy to opioids\n  * Allergy to paracetamol\n  * Creatinine clearance \\\u003C 30ml\u002Fmin\n  * Weight\\\u003C50 kg or \\>100kg\n  * Psychiatric disorders and difficulty of communication\n  * Lower limb neurological deficit\n  * Patients undergoing bilateral or revision total hip replacement","85 Years",{"count":573,"type":22},60,[25],"The Erector Spinae Plane (ESP) block or spinal erector block was first described in September 2016 by a Canadian team. It's a block that was initially used for the treatment of chronic thoracic neuropathic pain. The ESP block is one of the inter-fascicular blocks and it's an easy-to-perform technique.In the literature, it has been reported that Lumbar ESPB provides effective analgesia after a hip surgery.\n\nThe purpose of this prospective randomized study was to compare the analgesic effects of the ultrasound-guided lumbar Erector Spinae Plane block on postoperative pain management versus the multimodal analgesia after total hip arthroplasty.",[28],[435,578,579],"Lumbal Erector Spinae Plane Block","pain managment","2025-11-16",{"date":582,"type":38},"2025-11-21",{"date":584,"type":38},"2025-11-01",{"date":586,"type":22},"2026-07-07",{"name":588,"class":45},"University Tunis El Manar",{"id":590,"slug":591,"hasResults":12,"nctId":592,"briefTitle":593,"officialTitle":594,"acronym":595,"eligibilityCriteria":596,"healthyVolunteers":12,"sex":17,"minAge":91,"maxAge":4,"enrollmentInfo":597,"targetDuration":4,"studyType":23,"phases":599,"briefSummary":600,"conditions":601,"keywords":603,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":613,"lastUpdatePostDateStruct":614,"startDateStruct":616,"completionDateStruct":618,"leadSponsor":620,"locationsCount":46},"100603386","digital-home-based-physical-activity-promotion-for-older-adults-after-total-hip-arthroplasty-100603386","NCT07135843","Digital Home-Based Physical Activity Promotion for Older Adults After Total Hip Arthroplasty","iPATH - Digital Home-Based Training for Physical Activity Promotion in Older Adults After Total Hip Arthroplasty: A Randomized Controlled Trial","iPATH","Inclusion Criteria:\n\n* Age ≥65 years\n* Coxarthrosis with indication for total hip arthroplasty\n* Residence within a radius of ≤50 km from Heidelberg\n* Ability to walk ≥10 m (with\u002Fwithout walking aid)\n* Access to the internet (Wi-Fi) at home\n* Written informed consent\n\nExclusion Criteria:\n\n* Insufficient German language skills\n* Insufficient hearing to communicate via (video) telephone\n* Insufficient vision to recognize study materials\n* Contralateral coxarthrosis with indication for total hip arthroplasty\n* Severe medical condition illnesses that compromise physical fitness (heart failure classified as New York Heart Association \\[NYHA\\] class ≥3, heart valve defects associated with syncope, cardiac arrhythmia with dizziness, chronic obstructive pulmonary disease \\[COPD\\] with oxygen therapy, cancer with chemotherapy and\u002For radiation, Parkinson's disease with rollator use \\[Hoehn \\& Yahr stage ≥4\\])\n* Living in a nursing home\n* Planned major medical procedure within the next 6 months with inpatient hospital stay (e.g., further surgery)\n* Simultaneous participation in another competing study\n* Cognitive impairment (6-item Cognitive Impairment Test \\[6CIT\\] score \\>7 points)",{"count":598,"type":22},213,[25],"The goal of this clinical trial is to evaluate the efficacy of a 12-week digital home-based intervention program, consisting of a tablet-based exercise program with or without personal coaching, to promote physical activity (PA) in older adults after total hip arthroplasty (THA). The main question it aims to answer is:\n\n• Does the combination of the digital exercise program and personal coaching lead to higher PA six months after THA compared to usual care among older adults?\n\nSecondary questions are:\n\n* Does the digital exercise program alone lead to higher PA compared to usual care?\n* Does the digital exercise program combined with personal coaching lead to higher PA compared to the exercise program alone?\n\nParticipants' PA will be objectively measured with a body-fixed sensor at 1 week before THA (T1), 6 weeks after THA (T2), and 6 months (i.e. after THA (T3). After the postoperative assessment at T2, participants will be randomly assigned to one of three groups:\n\n* 12-week tablet-based exercise program at home with virtual personal coaching for physical activity promotion\n* 12-week tablet-based exercise program at home\n* Usual care (control group, no additional intervention)",[28,602],"Older Adults (65 Years and Older)",[483,604,605,606,607,608,609,610,611,612],"Physical Activity","Older Adults","Digital Intervention","Physical Exercise","Coaching","Patient Education","Postoperative Care","Ambulatory Monitoring","Behavior Change","2025-08-29",{"date":615,"type":38},"2025-09-02",{"date":617,"type":22},"2025-09",{"date":619,"type":22},"2028-01",{"name":621,"class":45},"Heidelberg University",{"id":623,"slug":624,"hasResults":12,"nctId":625,"briefTitle":626,"officialTitle":627,"acronym":628,"eligibilityCriteria":629,"healthyVolunteers":12,"sex":17,"minAge":55,"maxAge":4,"enrollmentInfo":630,"targetDuration":4,"studyType":23,"phases":632,"briefSummary":633,"conditions":634,"keywords":636,"overallStatus":175,"whyStopped":4,"lastUpdateSubmitDate":644,"lastUpdatePostDateStruct":645,"startDateStruct":647,"completionDateStruct":649,"leadSponsor":651,"locationsCount":46},"100596051","mri-based-assessment-of-local-anesthetic-spread-in-the-peng-block-compartment-100596051","NCT07040423","MRI-Based Assessment of Local Anesthetic Spread in the PENG Block Compartment","Evaluation of Local Anesthetic Distribution in the PENG Block Compartment Using Pelvic MRI","MRI-PENG","Inclusion Criteria:\n\n* Patients scheduled for total hip replacement surgery\n* Age ≥ 18 years\n* ASA physical status classification I-III\n* Signed informed consent obtained\n* Orthopedic indication for preoperative MRI study\n\nExclusion Criteria:\n\n* Allergy to local anesthetics\n* Infection at the planned puncture site\n* Refusal or inability to provide informed consent\n* Age \\\u003C 18 years\n* Claustrophobia\n* Altered consciousness or severe dementia\n* Presence of MRI-incompatible implanted devices (e.g., pacemakers implanted before 2000)\n* Pregnancy or breastfeeding",{"count":631,"type":22},6,[25],"This study uses MRI imaging to evaluate the spread of local anesthetic following the administration of a pericapsular nerve group (PENG) block. The goal is to determine whether a distinct fascial plane exists between neurovascular structures, potentially explaining the block's observed clinical effectiveness.",[28,635],"Postoperative Pain Management After Total Hip Arthroplasty",[637,638,206,639,408,640,641,642,643],"Anesthetics","Anesthetics, Local","Acute Pain","Pelvic MRI","Regional anesthesia","Fascial plane","Local anesthetic spread","2025-06-18",{"date":646,"type":38},"2025-06-27",{"date":648,"type":22},"2025-06",{"date":650,"type":22},"2026-10",{"name":652,"class":45},"Campus Bio-Medico University",{"id":654,"slug":655,"hasResults":12,"nctId":656,"briefTitle":657,"officialTitle":658,"acronym":4,"eligibilityCriteria":659,"healthyVolunteers":12,"sex":17,"minAge":55,"maxAge":660,"enrollmentInfo":661,"targetDuration":4,"studyType":23,"phases":663,"briefSummary":664,"conditions":665,"keywords":4,"overallStatus":175,"whyStopped":4,"lastUpdateSubmitDate":667,"lastUpdatePostDateStruct":668,"startDateStruct":670,"completionDateStruct":672,"leadSponsor":674,"locationsCount":46},"100588813","phase-4-assessing-the-time-course-of-dexmedetomidine-induced-analgesia-via-eeg-100588813","NCT06946277","Assessing the Time-Course of Dexmedetomidine-Induced Analgesia Via EEG","Mapping the Temporal Profile of Dexmedetomidine-Induced Analgesia Via EEG Signatures in Brain","Inclusion Criteria:\n\nPatients with hip osteoarthritis scheduled for total hip arthroplasty under intrathecal anesthesia; Age 18-70 years; American Society of Anesthesiologists (ASA) physical status classification I-III; Body mass index (BMI) 22-30 kg\u002Fm².\n\nExclusion Criteria:\n\nPre-existing peripheral or central nervous system disorders; Mental disorders; Cognitive impairment; Emergency surgery; or Hearing impairment.","70 Years",{"count":662,"type":22},20,[166],"Objective: To investigate the temporal dynamics of dexmedetomidine's analgesic effects in the brain using EEG.\n\nMethods: Eligible patients scheduled for total hip arthroplasty under intrathecal anesthesia received a continuous infusion of DEX at 1.5 μg\u002F(kg·h) for 15 minutes before neuraxial puncture, followed by an additional 15-minute infusion. The study was divided into three phases:\n\nPhase 1: Non-dosing phase (Baseline). Phase 2: DEX preemptive analgesia phase (DEX infusion). Phase 3: DEX cessation phase (Post-infusion).\n\nOutcomes:\n\nPrimary safety outcome: EEG spectral analysis at different phases. Secondary outcomes: NRS scores, postoperative nausea and vomiting (PONV), dizziness, agitation, and time to intestinal exhaust within 48 hours. Intraoperative hemodynamics were also monitored.",[28,666,529],"Intrathecal Anesthesia","2025-04-23",{"date":669,"type":38},"2025-04-27",{"date":671,"type":22},"2025-04-25",{"date":673,"type":22},"2025-05-26",{"name":675,"class":45},"China International Neuroscience Institution",{"id":677,"slug":678,"hasResults":12,"nctId":679,"briefTitle":680,"officialTitle":681,"acronym":4,"eligibilityCriteria":682,"healthyVolunteers":12,"sex":17,"minAge":55,"maxAge":325,"enrollmentInfo":683,"targetDuration":4,"studyType":131,"phases":4,"briefSummary":685,"conditions":686,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":687,"lastUpdatePostDateStruct":688,"startDateStruct":690,"completionDateStruct":692,"leadSponsor":694,"locationsCount":695},"100573638","mpact-3d-metal-monolit-study-100573638","NCT06748885","Mpact 3D Metal Monolit Study","Prospective, Multicentre, Non-randomised, Open Study Evaluating the Efficacy and Fixation of the Mpact 3D Metal Monolit Cup","Inclusion Criteria:\n\n1. Patient with a disease that corresponds to the indications for use of Medacta implants (according to the instructions for use)\n2. Patient eligible for primary total hip arthroplasty\n3. Patient aged between 18 and 75 years\n4. Patient covered by the French Social Security system or an equivalent protection scheme.\n5. Patient able, in the investigator's opinion, to comply with the requirements of the study.\n\nExclusion Criteria:\n\n1. Patient suffering from inflammatory arthritis\n2. Previously operated hip\n3. Patient requiring a transplant\n4. Hip tumour involved\n5. Patient with progressive local or systemic infection\n6. Severe acetabular dysplasia\n7. Patient with muscle loss, neuromuscular disease or vascular impairment of the affected limb.\n\n4\\. Patient with known medical problems that may compromise independent recovery of mobility 5. Patient with a BMI greater than 40 kg\u002Fm². 6. Patient with major cognitive impairment that prevents him\u002Fher from fully understanding the requirements of the study 7. Patient living in a geographical area where study follow-up is not possible. 8. Patient taking part in interventional research 9. Minor patient 10. Protected adult patient 11. Vulnerable person according to article L1121-6 of the Public Health Code",{"count":684,"type":22},88,"Total hip arthroplasty (THA) is one of the most common operations performed in orthopaedics to improve a patient's quality of life.\n\nSurgeons are constantly seeking to improve all aspects of care related to this procedure, whether it be improving implant technology, improving instrumentation or the technique involved in performing the procedure.\n\nIn recent years, a new porous titanium coating has been introduced to promote good osseointegration of uncemented cups. High friction torque and a feeling of immediate anchorage provide excellent primary stability, while high porosity ensures bone growth providing secondary stability. With higher porosity than standard coatings, a greater volume of bone can be present in the porous surface, giving a proportional increase in force at the interface. he Mpact 3D Metal Monolith cup has been designed to provide greater range of motion and improved joint stability, with a reduced risk of dislocation. It is an innovative design that improves stability and provides a favourable environment for long-term biological metal-bone fixation.\n\nThe current study aims to collect clinical and radiological data to assess the function of the operated hip and the stability of the Mpact 3D Metal Monolith cup at 2 years and survival at 5 years for the treatment of patients requiring hip arthroplasty.",[28],"2024-12-23",{"date":689,"type":38},"2024-12-27",{"date":691,"type":38},"2024-02-28",{"date":693,"type":22},"2030-12",{"name":243,"class":154},3]